Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Gross Profit (2016 - 2025)

Jaguar Health (JAGX) has disclosed Gross Profit for 11 consecutive years, with -$2.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Gross Profit fell 357.92% to -$2.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $7.8 million, a 36.33% increase, with the full-year FY2024 number at $9.7 million, up 26.02% from a year prior.
  • Gross Profit was -$2.8 million for Q3 2025 at Jaguar Health, down from $2.5 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $6.5 million in Q4 2024 to a low of -$5.0 million in Q4 2021.
  • A 5-year average of $883473.7 and a median of $1.6 million in 2021 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: plummeted 384.97% in 2021, then surged 931.82% in 2024.
  • Jaguar Health's Gross Profit stood at -$5.0 million in 2021, then rose by 18.46% to -$4.0 million in 2022, then surged by 228.64% to $5.2 million in 2023, then rose by 25.79% to $6.5 million in 2024, then plummeted by 143.36% to -$2.8 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Gross Profit are -$2.8 million (Q3 2025), $2.5 million (Q2 2025), and $1.7 million (Q1 2025).